News Newron Pharmaceuticals S.p.A.

Equities

NWRN

IT0004147952

Delayed Swiss Exchange Other stock markets 04:41:03 2024-04-18 am EDT			5-day change	1st Jan Change
6.98 ^CHF	-3.72%		-4.76%	+41.41%

Mar. 19	Newron Pharmaceuticals S.p.A. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Mar. 19	Transcript : Newron Pharmaceuticals S.p.A., 2023 Earnings Call, Mar 19, 2024

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Newron Pharmaceuticals S p A : announces AGM 2024 results	Apr. 17	PU
Data from Newron’s study 014/015 and an evenamide clinical development outlook presented at the 2024 Annual Congress of the Schizophrenia International Research Society (SIRS)	Apr. 08	BU
Data from Newron’s study 014/015 and an evenamide clinical development outlook presented at the 2024 Annual Congress of the Schizophrenia International Research Society (SIRS)	Apr. 08	EQ
Newron Pharmaceuticals S p A : Invitation to attend the General Meeting	Mar. 27	PU
Newron Pharmaceuticals S.p.A. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 19	CI
Transcript : Newron Pharmaceuticals S.p.A., 2023 Earnings Call, Mar 19, 2024	Mar. 19
Newron Presents 2023 Financial Results and Provides 2024 Outlook	Mar. 19	BU
Newron Pharmaceuticals' FY23 Loss Narrows; Revenue Up	Mar. 19	MT
Newron presents 2023 financial results and provides 2024 outlook	Mar. 19	EQ
Newron announces agreement with the European Investment Bank (EIB) to extend the near-term tranche repayment dates of its 2018 financing agreement	Mar. 15	BU
Newron Pharmaceuticals S.p.A. Announces Agreement with the European Investment Bank to Extend the Near-Term Tranche Repayment Dates of Its 2018 Financing Agreement	Mar. 15	CI
Newron Pharmaceuticals Secures Extension on Three Loan Repayments	Mar. 15	MT
Newron announces agreement with the European Investment Bank (EIB) to extend the near-term tranche repayment dates of its 2018 financing agreement	Mar. 15	EQ
Newron Pharmaceuticals Investor Subscribes for Nearly EUR6 Million Shares	Mar. 15	MT
Newron enters into an agreement for the subscription of up to 2.05 million newly issued shares; Proceeds of up to EUR 15.0 million	Mar. 14	EQ
Swiss Equities Edge Higher as Markets Continue to Weigh Rate Cut Outlook	Jan. 04	MT
Transcript : Newron Pharmaceuticals S.p.A. - Special Call	Jan. 04
Newron Reports Exceptional One-year Results of Study 014/15 With Evenamide in Treatment-resistant Schizophrenia (TRS)	Jan. 04	BU
Newron Reports Exceptional One-Year Results of Study 014/15 with Evenamide in Treatment-Resistant Schizophrenia	Jan. 04	CI
Newron Pharmaceuticals' Schizophrenia Drug Lowers Disease Severity in Clinical Studies	Jan. 04	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Newron Pharmaceuticals S.p.A.

Equities

NWRN

IT0004147952

Summary

Filters